Early loss of the retinoblastoma gene is associated with impaired growth inhibitory innervation during melanotroph carcinogenesis in Rb+/- mice.
To better understand the cell lineage-specific character of retinoblastoma (Rb) gene inactivation during tumor formation, the earliest stages of spontaneous melanotroph carcinogenesis in Rb+/- heterozygous mice have been subjected to sequential analyses. The first atypical cells are detected in the pituitary intermediate lobe during a period corresponding to the cessation of melanotroph proliferation between 35 and 60 days after birth. Atypical cells contain no wild-type copy of the Rb gene and synchronously form early atypical proliferates (EAP) in the subsequent 30-60 day period. In contrast to surrounding mature melanotrophs with the wild-type Rb gene, Rb-negative cells in EAP continue to proliferate well past postnatal day 60, and fail to be innervated by growth inhibitory dopaminergic nerve terminals. Atypical melanotrophs remain competent for dopamine D2 receptor stimulation and undergo S-phase apoptosis in close proximity to nerve terminals. These results indicate a key role for the Rb protein in the onset of neuron-neuroendocrine cell interactions. This role may explain cell-type-specific neuroendocrine carcinogenesis associated with inactivation of the ubiquitously expressed Rb gene.
Nikitin AYu
Center for Molecular Medicine/Institute of Biotechnology, University of Texas Health Science Center at San Antonio 78245, USA.
Lee
W H
WH
D000818:Animals; D000831:Animals, Newborn; D001483:Base Sequence; D001971:Bromocriptine / Q000494:pharmacology; D002455:Cell Division; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D004298:Dopamine / Q000378:metabolism; D018491:Dopamine Agonists / Q000494:pharmacology; D017353:Gene Deletion; D015972:Gene Expression Regulation, Neoplastic; D016161:Genes, Retinoblastoma / Q000235:genetics*; D006579:Heterozygote; D051379:Mice; D008817:Mice, Mutant Strains; D008969:Molecular Sequence Data; D010902:Pituitary Gland / Q000254:growth & development / Q000294:innervation* / Q000473:pathology*; D010911:Pituitary Neoplasms / Q000139:chemically induced / Q000235:genetics* / Q000473:pathology; D011954:Receptors, Dopamine / Q000378:metabolism; D014407:Tumor Cells, Cultured / Q000187:drug effects
D018491:Dopamine Agonists; D011954:Receptors, Dopamine; D001971:Bromocriptine; D004298:Dopamine